Literature DB >> 9365161

Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase and creatine kinase activity and isoenzymes in human brain tumours.

N Durany1, J Joseph, F F Cruz-Sánchez, J Carreras.   

Abstract

The distribution of phosphoglycerate mutase (EC 5.4.2.1, PGM), 2,3-bisphosphoglycerate phosphatase (EC 3.1.3.13, BPGP) and creatine kinase (EC 2.7.3.2, CK) activity and isoenzymes in various regions of adult human brain and in brain tumours (astrocytomas, anaplastic astrocytomas, glioblastomas and meningiomas) has been determined using electrophoresis. PGM and cytosolic CK exist in mammalian tissues as three isoenzymes that result from the homodimeric and heterodimeric combinations of two subunits [types M (muscle) and B (brain)] coded by separated genes. In addition, a dimeric form and an octameric form of mitochondrial CK exist in mammals. Type BB-PGM was the major PGM isoenzyme found in normal brain, although type MB-PGM and type MM-PGM were also detected. All brain tumours possessed lower PGM activity than normal brain, and meningiomas showed higher BPGP activity. In astrocytic tumours, the proportion of type MB- and type MM-PGM decreased, and in meningiomas these isoenzymes were not detected. Type BB-CK and mitochondrial CK were the only CK isoenzymes detected in normal brain. Astrocytomas possessed lower CK activity than anaplastic astrocytomas and glioblastomas and, in addition, tended to possess lower CK content than normal brain. No qualitative changes of the normal CK isoenzyme pattern were observed in the tumours.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9365161      PMCID: PMC2228130          DOI: 10.1038/bjc.1997.525

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  53 in total

1.  Measurement of brain-specific creatine kinase isoenzyme activity in serum.

Authors:  D A Nealon; A R Henderson
Journal:  Clin Chem       Date:  1975-10       Impact factor: 8.327

2.  Creatine kinase isoenzyme patterns in human tissue obtained at surgery.

Authors:  S H Tsung
Journal:  Clin Chem       Date:  1976-02       Impact factor: 8.327

3.  Serum creatine phosphokinase (CPK ) isoenzymes after intramuscular injections, surgery, and myocardial infarction. Experimental and clinical studies.

Authors:  M S Klein; W E Shell; B E Sobel
Journal:  Cardiovasc Res       Date:  1973-05       Impact factor: 10.787

4.  Phosphoglycerate mutase isozyme marker for tissue differentiation in man.

Authors:  G S Omenn; S C Cheung
Journal:  Am J Hum Genet       Date:  1974-05       Impact factor: 11.025

5.  Separation of tissue and serum creatine kinase isoenzymes by ion-exchange column chromatography.

Authors:  D W Mercer
Journal:  Clin Chem       Date:  1974       Impact factor: 8.327

6.  Cytoplasmic creatine kinase isoenzymes quantitated in tissue specimens obtained at surgery.

Authors:  P Urdal; K Urdal; J H Strømme
Journal:  Clin Chem       Date:  1983-02       Impact factor: 8.327

7.  An improved basis for enzymatic estimation of infarct size.

Authors:  R Roberts; P D Henry; B E Sobel
Journal:  Circulation       Date:  1975-11       Impact factor: 29.690

8.  Creatin kinase in human tissues.

Authors:  D M Dawson; I H Fine
Journal:  Arch Neurol       Date:  1967-02

9.  Quantitation of creatine kinase isoenzymes in human tissues and sera by an immunological method.

Authors:  E Jockers-Wretou; G Pfleiderer
Journal:  Clin Chim Acta       Date:  1975-02-08       Impact factor: 3.786

10.  Formation of an unusual hybrid in the development of human adenosine 5'-triphosphate-creatine phosphotransferase.

Authors:  I Kumudavalli; D C Watts
Journal:  Biochem J       Date:  1968-07       Impact factor: 3.857

View more
  5 in total

Review 1.  Anticancer agents that counteract tumor glycolysis.

Authors:  Carlotta Granchi; Filippo Minutolo
Journal:  ChemMedChem       Date:  2012-06-08       Impact factor: 3.466

2.  Phosphoglycerate mutase 1 promotes cancer cell migration independent of its metabolic activity.

Authors:  D Zhang; N Jin; W Sun; X Li; B Liu; Z Xie; J Qu; J Xu; X Yang; Y Su; S Tang; H Han; D Chen; J Ding; M Tan; M Huang; M Geng
Journal:  Oncogene       Date:  2016-12-19       Impact factor: 9.867

3.  Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase, creatine kinase and enolase activity and isoenzymes in breast carcinoma.

Authors:  N Durany; J Joseph; O M Jimenez; F Climent; P L Fernández; F Rivera; J Carreras
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

4.  Systematic analysis of transcription-level effects of neurodegenerative diseases on human brain metabolism by a newly reconstructed brain-specific metabolic network.

Authors:  Mustafa Sertbaş; Kutlu Ulgen; Tunahan Cakır
Journal:  FEBS Open Bio       Date:  2014-06-06       Impact factor: 2.693

5.  Identification of Epigallocatechin-3- Gallate as an Inhibitor of Phosphoglycerate Mutase 1.

Authors:  Xiaoguang Li; Shuai Tang; Qian-Qian Wang; Elaine L-H Leung; Hongyue Jin; Yongzhuo Huang; Jia Liu; Meiyu Geng; Min Huang; Shengtao Yuan; Xiao-Jun Yao; Jian Ding
Journal:  Front Pharmacol       Date:  2017-05-30       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.